Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for 180 Life Sciences Corp. (ATNF : NSDQ)
 
 • Company Description   
180 Life Sciences Corp. is a clinical-stage biotechnology company. It is focused on the development of novel drugs for unmet needs in inflammatory diseases, fibrosis and pain. 180 Life Sciences Corp., formerly known as KBL Merger Corp. IV, is based in MENLO PARK, Calif.

Number of Employees: 2

 
 • Price / Volume Information   
Yesterday's Closing Price: $10.26 Daily Weekly Monthly
20 Day Moving Average: 328,087 shares
Shares Outstanding: 18.03 (millions)
Market Capitalization: $185.01 (millions)
Beta: -0.24
52 Week High: $13.05
52 Week Low: $1.90
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 25.43% 24.07%
12 Week 56.40% 46.49%
Year To Date 275.82% 232.79%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
150 WEST 56TH STREET SUITE 5901
-
NEW YORK,NY 10019
USA
ph: 302-502-2727
fax: -
jason@180lifesciences.com http://www.180lifesciences.com
 
 • General Corporate Information   
Officers
Marlene Krauss - Chief Executive Officer and Director
George Hornig - Chairman
Joseph A. Williamson - Chief Operating Officer and Director
Andrew Sherman - Director
Sherrill Neff - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 68236V104
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/20
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 18.03
Most Recent Split Date: (:1)
Beta: -0.24
Market Capitalization: $185.01 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 11.40
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/21 - -
12/31/20 - -
09/30/20 - -158.61
ROA
03/31/21 - -
12/31/20 - -
09/30/20 - -64.56
Current Ratio
03/31/21 - -
12/31/20 - -
09/30/20 - 0.11
Quick Ratio
03/31/21 - -
12/31/20 - -
09/30/20 - 0.18
Operating Margin
03/31/21 - -
12/31/20 - -
09/30/20 - -
Net Margin
03/31/21 - -
12/31/20 - -
09/30/20 - -
Pre-Tax Margin
03/31/21 - -
12/31/20 - -
09/30/20 - -
Book Value
03/31/21 - -
12/31/20 - -
09/30/20 - 0.90
Inventory Turnover
03/31/21 - -
12/31/20 - -
09/30/20 - -
Debt-to-Equity
03/31/21 - -
12/31/20 - -
09/30/20 - 0.00
Debt-to-Capital
03/31/21 - -
12/31/20 - -
09/30/20 - 0.00
 

Powered by Zacks Investment Research ©